Medical and Health Science Journal

  Previous Article | Back to Volume | Next Article
  Abstract | References | Citation | Download | Preview | Statistics
Volume 6
Issue 2
Online publication date 2011-04-04
Title Medical and social factors of relapse development in patients with multidrug resistant tuberculosis
Author Elmira Berikova, Shakhmurat Ismailov, Mayra Zhaparkulova
Abstract Case-control study data of 637 multidrug resistance TB patients, successfully completed treatment course with first line anti-TB drugs plus pyrazinamide, revealed main medical and social factors of the disease recurrence. All patients were treated 4 or 5 months in clinic under standardized directly observed regimes and 18-24 months in out-patient surveillance. Relapse development was noted in 21 cases and significantly more often appeared in patients living alone and aged 30 to 40 years old.
Berikova, E., Zhaparkulova, M., 2010. “Study of the reasons of relapses emergence in patients with MDR TB treated under regimen DOTS-Plus,” Health and Disease [Zdorove i Bolezni], in Russian, Almaty, No.2(87), pp.135-41

Ismailov, Sh., 2003. “The general orientations in control over tuberculosis with multidrug resistance in the Republic of Kazakhstan,” Journal of Phthisiopulmonology [Jurnal Phthisiopulmonologiya], in Russian, No.2(4), pp.8-10

Ismailov, Sh., 2009. “Statistical review on tuberculosis in the Republic of Kazakhstan” [Statisticheskiy obzor po tuberkulozu v Respublike Kazakhstan], in Russian, Almaty

Kolomijetz, V., 1982. “Reactivation of pulmonary tuberculosis and its prevention at forming the groups of higher TB risk” [Reaktivaziy tuberkuloza legkikh i eje profilaktika pri formirovanii gruo povyshennogo riska], in Russian, Synopsis of PhD dissertation, Ukraine, Kiev

Kovalenko, I., 1989. “Reactivation of pulmonary tuberculosis” [Reaktivazija tuberkuloza legkikh], in Russian, Kishinev, Moldova

Laserson, K., Thorpe, L., Leimane, V. et al., 2005. “Speaking the same language: Treatment outcome definitions for multidrug resistant tuberculosis,” Intern.Journ.Tuberc.Lung Dis., 9, pp.640-45

MHRK, 2008. “On statement of the Guidelines on Management of tuberculosis  with multidrug resistance” [Ob utverzhdenii inctrukcii po vedeniyu bolnikh tuberkulozom s mnozhestvennoy liekarstvennoy ustoychivostyu], in Russian, Order No.723, December 7, Ministry of Health, Republic of Kazakhstan, Almaty

Migliori, G., Espinal, M., Danilova, I. et al., 2002. “Frequency of relapses in patients with MDR TB “successfully” cured with standartized short course of  chemotherapy,” Intern.Journal of Tuberc.and Lung Dis., Vol.6(10), pp.858-64

Mishin, V., 2008. “Chemotherapy of pulmonary TB,” Journal of Pulmonology [Journal Pulmonologia], in Russian, No.3, pp.5-14

Mukherjee, D., Rich, M., Socci, A. et al., 2004. “Programmers and principles in treatment of multidrug resistant tuberculosis”. Journ. Lancet. 363, pp.474-81

Mukherjee, D., Shin, S., Furin, D. et al., 2006. “The new problems in treatment of tuberculosis with multidrug resistant tuberculosis,” Partners in Health. In collection of papers on problems of multidrug resistant tuberculosis [Sbornik nauchnikh statey po probleme tuberkuloza s mnozhestvennoy liekarstvennoy ustojchivostyu], in Russian. Tomsk, Russia, Issue 3, pp.3-20

Partners in Health, 2002. A DOTS-Plus Handbook. Guide to the Community-based Treatment of MDR TB, Program in Infectious Disease and Social Change, Department of Social Medicine, Harvard Medical School
WHO, 2004. Global tuberculosis control: Surveillance, planning financing, World Health Organization, Geneva

WHO, 2007. Guidelines for surveillance of drug resistance in tuberculosis, Geneva, World Health Organization

WHO, 2008. Guidelines for the programmatic management of drug resistant tuberculosis, Geneva, World Health Organization

Zignol, M. et al., 2005. “Global incidence of multidrug - resistant tuberculosis, Global incidence of multidrug-resistant tuberculosis”. Abstract for the CDC late-breaker session of the 36th World Conference on Lung Health, Paris

Keywords Multidrug resistant tuberculosis, relapses, medical and social factors
Pages 88-93
Download Full PDF Download
  Previous Article | Back to Volume | Next Article
Search in articles
Journal Published articles
MHSJ 940
Journal Hits
MHSJ 2562120
Journal Downloads
MHSJ 17477
Total users online -